Govt targets WHO-recommended doctor-patient ratio: NMC Chairman

New Delhi: National Medical Commission (NMC) Chairman Dr Abhijat Sheth on Saturday emphasised the government’s commitment to uniformly increasing the number of doctors across the country to meet the WHO-recommended doctor-patient ratio of 1:1000.

He said this while presiding over the 11th convocation ceremony of the Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and Dr Ram Manohar Lohia Hospital here, news agency PTI reported.

Sheth congratulated the graduating students as well as their parents and faculty members for their dedication in guiding and motivating them towards a service in healthcare.

Also Read:Doctors undergoing PG medical courses without joining duty not entitled to salary: HC

He emphasised the government’s commitment to increasing the number of doctors in the country to meet the World Health Organization’s recommendation of maintaining a uniform doctor-patient ratio of 1:1000 countrywide.

The NMC chairman also shared information about ongoing efforts to achieve a balanced undergraduate (UG) to postgraduate (PG) ratio of 1:1, aiming to elevate the quality of India’s healthcare system to the standards of developed countries.

He also highlighted innovative initiatives being introduced by the National Board of Examinations in Medical Sciences and the NMC, such as integrating skill-based and virtual learning alongside traditional physical education, to fulfil the requirements of competency-based medical education.

Sheth encouraged the students to prioritise their own health and well-being to persevere through challenges and remain lifelong learners.

In her address to the graduating students, Director General of Health Services (DGHS) Dr Sunita Sharma said, “You are not merely receiving a degree today, you are shouldering a profound responsibility — to heal, to lead and to serve the nation in whatever capacity you choose.”

Whether pursuing clinical care, medical research or education, she advised, “Let your work be driven by empathy, evidence and excellence.”

Emphasising the sanctity of the medical profession, Sharma said, “This is a noble calling built on compassion and an unwavering commitment to human life”, reports PTI.

She encouraged the graduates to remain humble and grounded, no matter how far they go or how much they achieve in life.

Also Read:Karnataka PPP model trains over 300 DNB doctors, strengthens specialist healthcare access

Powered by WPeMatico

UP NEET Counselling 2025: 3864 MBBS, BDS seats up for grabs in Round 2, choice filling till September 23

Uttar Pradesh- The Department of Medical Education and Training (UPDGME) has released the National Eligibility and Entrance Test-Undergraduate (NEET UG) round 2 counselling seat matrix for the academic year 2025. The seat matrix has been released in a PDF format on the official website of UPDGME.

The counselling dates:

Date of On-line Choice filling From: 19-09-2025 (05:00 PM) 04 Days To 23-09-2025 (11:00 AM).

Date of Allotment Result Declaration On :-24-09-2025 01 Day 

Date for downloading the allotment letters & Admission From:- 25-09-2025 To :-27-09-2025 & From:- 29-09-2025 To :-30-09-2025 & On:-03-10-2025 

The seat matrix contains important details such as Course Name & Code, UP NEET UG Seat, category, status, and total vacant seats. As per the seat matrix, a total of 3864 seats are vacant across BDS and MBBS colleges. Of these, a total of 3259 seats are vacant for MBBS and a total of 605 seats are vacant for BDS courses.

 Below is the detailed seat matrix-

Also Read: UP DGME notifies schedule, guidelines for NEET SS 2021 batch counselling for Assistant professor posts under Bond Service

MBBS SEAT MATRIX

S.NO

COLLEGES

TOTAL VACANT SEATS

1

AUTONOMOUS STATE MEDICAL COLLEGE, BAHRAICH.

4

2

AUTONOMOUS STATE MEDICAL COLLEGE, BASTI.

5

3

AUTONOMOUS STATE MEDICAL COLLEGE, DEORIA.

3

4

AUTONOMOUS STATE MEDICAL COLLEGE, ETAH.

8

5

AUTONOMOUS STATE MEDICAL COLLEGE, FATEHPUR.

3

6

AUTONOMOUS STATE MEDICAL COLLEGE, FIROZABAD.

13

7

AUTONOMOUS STATE MEDICAL COLLEGE, GHAZIPUR.

5

8

AUTONOMOUS STATE MEDICAL COLLEGE, HARDOI.

7

9

AUTONOMOUS STATE MEDICAL COLLEGE, JAUNPUR.

5

10

AUTONOMOUS STATE MEDICAL COLLEGE, MIRZAPUR.

2

11

AUTONOMOUS STATE MEDICAL COLLEGE, PRATAPGARH.

9

12

AUTONOMOUS STATE MEDICAL COLLEGE, SHAHJAHANPUR.

10

13

AUTONOMOUS STATE MEDICAL COLLEGE, SIDDHARTH NAGAR.

9

14

BABA RAGHAVDAS MEDICAL COLLEGE, GORAKHPUR.

8

15

DR.RAM MANOHAR LOHIA INSTITUTE OF MEDICAL SCIENCES, GOMTI NAGAR, LUCKNOW.

30

16

GANESH SHANKER VIDHARTHI MEMORIAL MEDICAL COLLEGE, KANPUR.

22

17

GOVERNMENT MEDICAL COLLEGE, AZAMGARH.

11

18

GOVERNMENT MEDICAL COLLEGE, BADAUN.

11

19

GOVERNMENT MEDICAL COLLEGE, BANDA.

6

20

GOVERNMENT INSTITUTE OF MEDICAL SCIENCES, GREATER NOIDA.

16

21

KING GEORGE MEDICAL UNIVERSITY, LUCKNOW.

70

22

LALA LAJPAT RAI MEMORIAL MEDICAL COLLEGE, MEERUT.

9

23

MAHARANI LAXMIBAI MEDICAL COLLEGE, JHANSI.

9

24

MOTI LAL NEHRU MEDICAL COLLEGE, PRAGYRAJ.

12

25

SAROJINI NAIDU MEDICAL COLLEGE, AGRA.

12

26

UTTAR PRADESH UNIVERSITY OF MEDICAL SCIENCES, SAIFAI, ETAWAH.

14

27

AUTONOMOUS STATE MEDICAL COLLEGE, BIJNOR.

5

28

AUTONOMOUS STATE MEDICAL COLLEGE, BULANDSHAHR.

5

29

AUTONOMOUS STATE MEDICAL COLLEGE, KANPUR DEHAT.

9

30

AUTONOMOUS STATE MEDICAL COLLEGE, KUSHINAGAR.

8

31

AUTONOMOUS STATE MEDICAL COLLEGE, LALITPUR.

12

32

AUTONOMOUS STATE MEDICAL COLLEGE, PILIBHIT.

6

33

AUTONOMOUS STATE MEDICAL COLLEGE, SULTANPUR.

6

34

AUTONOMOUS STATE MEDICAL COLLEGE, AYODHYA.

13

35

GOVERNMENT MEDICAL COLLEGE, AMBEDKAR NAGAR.

10

36

GOVERNMENT MEDICAL COLLEGE, JALAUN.

9

37

GOVERNMENT MEDICAL COLLEGE, KANNAUJ.

6

38

GOVERNMENT MEDICAL COLLEGE, SAHARANPUR.

11

39

AUTONOMOUS STATE MEDICAL COLLEGE, AURAIYA.

4

40

AUTONOMOUS STATE MEDICAL COLLEGE, CHANDAULI.

7

41

AUTONOMOUS STATE MEDICAL COLLEGE, GONDA.

4

42

AUTONOMOUS STATE MEDICAL COLLEGE, KAUSHAMBI.

8

43

AUTONOMOUS STATE MEDICAL COLLEGE, LAKHIMPUR KHIRI.

7

44

AUTONOMOUS STATE MEDICAL COLLEGE, SONBHADRA.

9

45

ESIC MEDICAL COLLEGE AND HOSPITAL, NOIDA.

17

46

AUTONOMOUS STATE MEDICAL COLLEGE, AMETHI.

43

47

AJAY SANGAAL INSTITUTE OF MEDICAL SCIENCE & RESEARCH & AYUSHMAAN HOSPITAL, SHAMLI [ PPP].

90

48

KMC MEDICAL COLLEGE & HOSPITAL, MAHARAJGANJ.

42

49

SHRI SIDDHI VINAYAK MEDICAL COLLEGE & HOSPITAL, SAMBHAL.

65

50

CAREER INSTITUTE OF MEDICAL SCIENCES, LUCKNOW (MUSLIM MINORITY).

26

51

ERA’S LUCKNOW MEDICAL COLLEGE, LUCKNOW (MUSLIM MINORITY).

21

52

F.H. MEDICAL COLLEGE, AGRA (MUSLIM MINORITY).

67

53

INTEGRAL INSTITUTE OF MEDICAL SCIENCES & & RESEARCH, LUCKNOW (MUSLIM MINORITY).

39

54

TEERTHANKAR MAHAVEER MEDICAL COLLEGE & RESEARCH CENTRE, MORADABAD (JAIN MINORITY).

70

55

CAREER INSTITUTE OF MEDICAL SCIENCES & HOSPITAL, LUCKNOW.

40

56

ERA’S LUCKNOW MEDICAL COLLEGE & HOSPITAL, LUCKNOW.

36

57

F.H. MEDICAL COLLEGE, AGRA.

101

58

G S MEDICAL COLLEGE & HOSPITAL, HAPUR.

81

59

HERITAGE INSTITUTE OF MEDICAL SCIENCES, VARANASI.

27

60

HIND INSTITUTE OF MEDICAL SCIENCES, BARABANKI.

28

61

HIND INSTITUTE OF MEDICAL SCIENCES, SITAPU.

47

62

INTEGRAL INSTITUTE OF MEDICAL SCIENCES & RESEARCH, LUCKNOW.

59

63

KANTI DEVI MEDICAL COLLEGE, HOSPITAL & RESEARCH CENTRE, MATHURA.

65

64

KRISHNA MOHAN MEDICAL COLLEGE & HOSPITAL, MATHURA.

98

65

MAYO INSTITUTE OF MEDICAL SCIENCES, BARABANKI.

58

66

MUZAFFARNAGAR MEDICAL COLLEGE, MUZAFFARNAGAR.

54

67

NARAINA MEDICAL COLLEGE & RESEARCH CENTER, KANPUR, (0.

125

68

NATIONAL CAPITAL REGION INSTITUTE OF MEDICAL SCIENCES, MEERUT.

150

69

NOIDA INTERNATIONAL INSTITUTE OF MEDICAL SCIENCES, GREATER NOIDA.

71

70

PRASAD INSTITUTE OF MEDICAL SCIENCES, LUCKNOW.

43

71

RAJSHREE MEDICAL RESEARCH INSTITUTE, BAREILLY.

129

72

RAMA MEDICAL COLLEGE HOSPITAL, & RESEARCH CENTRE, HAPUR.

45

73

RAMA MEDICAL COLLEGE HOSPITAL, & RESEARCH CENTRE, KANPUR.

39

74

ROHILKHAND MEDICAL COLLEGE & HOSPITAL, BAREILLY.

116

75

SARASWATI INSTITUTE OF MEDICAL SCIENCES, HAPUR.

47

76

SARASWATI MEDICAL COLLEGE, UNNAO.

40

77

SCHOOL OF MEDICAL SCIENCES & RESEARCH AND SHARDA HOSPITAL, GREATER NOIDA.

123

78

SHRI GORAKSHNATH MEDICAL COLLEGE HOSPITAL & RESEARCH CENTER, SONBARSA, GORAKHPUR.

58

79

SKS HOSPITAL MEDICAL COLLEGE & RESEARCH CENTER, MATHURA.

80

80

SRI RAMMURTI SMARAK INSTITUTE OF MEDICAL SCIENCES, BAREILLY.

138

81

SUBHARTI MEDICAL COLLEGE, MEERUT.

64

82

T.S.MISRA MEDICAL COLLEGE & HOSPITAL, LUCKNOW.

133

83

TEERTHANKAR MAHAVEER MEDICAL COLLEGE & RESEARCH CENTRE, MORADABAD.

57

84

UNITED INSTITUTE OF MEDICAL SCIENCES, PRAYAGRAJ.

34

85

VARUNARJUN MEDICAL COLLEGE & ROHILKHAND HOSPITAL, SHAHJAHANPUR.

67

86

VENKATESWARA INSTITUTE OF MEDICAL SCIENCES, GAJRAULA, AMROAHA.

44

87

DR. B.S. KUSHWAH INSTITUTE OF MEDICAL COLLEGE, KANPUR.

30

TOTAL

3259

BDS SEAT MATRIX

S.NO

COLLEGES

TOTAL VACANT SEATS

1

BBD COLLEGE OF DENTAL SCIENCES, LUCKNOW.

60

2

CAREER POST GRADUATE INSTITUTE OF DENTAL SCIENCES & HOSPITAL, LUCKNOW.

11

3

CAREER POST GRADUATE INSTITUTE OF DENTAL SCIENCES & HOSPITAL, LUCKNOW (MUSLIM MINORITY).

2

4

CHANDRA DENTAL COLLEGE & HOSPITAL, BARABANKI.

12

5

D.J.COLLEGE OF DENTAL SCIENCES & RESEARCH, MODINAGAR, GHAZIABAD.

17

6

D.J. COLLEGE OF DENTAL SCIENCES & RESEARCH, MODINAGAR, GHAZIABAD (SIKHS MINORITY).

49

7

DENTAL COLLEGE, AZAMGARH.

17

8

INDERPRASTHA DENTAL COLLEGE & HOSPITAL, GHAZIABAD.

27

9

INSTITUTE OF DENTAL SCIENCES, BAREILLY.

9

10

INSTITUTE OF DENTAL STUDIES & TECHNOLOGIES, MODINAGAR, GHAZIABAD.

33

11

ITS CENTER FOR DENTAL STUDIES & RESEARCH, GHAZIABAD.

28

12

ITS DENTAL COLLEGE, HOSPITAL & RESEARCH CENTER, GREATER NOIDA.

15

13

K.D. DENTAL COLLEGE & HOSPITAL, MATHURA.

32

14

KALKA DENTAL COLLEGE, MEERUT.

33

15

KOTHIWAL DENTAL COLLEGE & RESEARCH CENTER, MORADABAD.

20

16

MAHARANA PRATAP DENTAL COLLEGE & HOSPITAL, KANPUR.

32

17

PURVANCHAL INSTITUTE OF DENTAL SCIENCE, GORAKHPUR.

17

18

RAMA DENTAL COLLEGE HOSPITAL & RESEARCH CENTER, KANPUR.

21

19

SARASWATI DENTAL COLLEGE & HOSPITAL, LUCKNOW.

16

20

SARDAR PATEL POST GRADUATE INSTITUTE OF DENTAL & MEDICAL SCIENCES, LUCKNOW.

18

21

SCHOOL OF DENTAL SCIENCES, SHARDA UNIVERSITY, GREATER NOIDA.

24

22

SHREE BANKEY BIHARI DENTAL COLLEGE & RESEARCH CENTER, GHAZIABAD.

25

23

SUBHARTI DENTAL COLLEGE & HOSPITAL, MEERUT.

25

24

TEERTHANKER MAHAVEER DENTAL COLLEGE & RESEARCH CENTRE, MORADABAD (JAIN MINORITY).

37

25

TEERTHANKAR MAHAVEER DENTAL COLLEGE & RESEARCH CENTER, MORDABAD.

11

26

FACULTY OF DENTAL SCIENCES, KGMU, LUCKNOW.

14

TOTAL

605

To view the seat matrix, click the link below

https://medicaldialogues.in/pdf_upload/updgme-releases-neet-2025-round-2-counselling-seat-matrix-3864-mbbs-bds-seats-vacant-301636.pdf

Powered by WPeMatico

Genetic study maps how the eye’s fovea develops for sharp vision

Combining artificial intelligence and genetics has allowed researchers to study the part of the eye that gives us sharp central vision in amazing detail for the first time.

Powered by WPeMatico

Study highlights overlooked link between vascular disease and dementia risk

Vascular dementia—cognitive impairment caused by disease in the brain’s small blood vessels—is a widespread problem, but it has not been as thoroughly studied as Alzheimer’s disease, in which abnormal plaques and protein tangles are deposited in neural tissue.

Powered by WPeMatico

New initiative targets faster shock diagnosis and care with ‘door to lactate clearance’

A new initiative by The Society for Cardiovascular Angiography & Interventions (SCAI) proposes a new framework and call to action for managing cardiogenic shock (CS), establishing lactate clearance potentially as the standardized, time-based marker of patient trajectory to improve outcomes in one of the deadliest cardiovascular emergencies.

Powered by WPeMatico

New study may help uncover the true impact of childhood lead exposure

Lead exposure in childhood may be even more dangerous for cognitive development and school performance than previously thought, according to a new analysis led by data scientist Joe Feldman.

Powered by WPeMatico

Metabolism does more than fuel embryonic growth—it also controls the tempo of development, researchers discover

Pregnant women rely on a balanced diet and supplements to deliver proper nutrients to their babies, to ensure they grow healthfully. Such nutrients contribute to fueling development and providing cellular building blocks that lead to healthy brains, bones, organs, and immune systems.

Powered by WPeMatico

AICTS Pune hosts National Pulmonology Conference with leading experts

Pune: The Army Institute of Cardio Thoracic Sciences (AICTS), Pune, is hosting the Association of Physicians of India (API) – Armed Forces Medical Services (AFMS) National Pulmonology Conference from 18th to 20th September 2025. 

This prestigious event brings together leading experts in Pulmonary Medicine from the Armed Forces and premier academic institutions across the country to discuss advancements and strategies for improving care for patients with respiratory diseases.

The conference commenced on 18th September with seven hands-on workshops, attended by over 300 residents and nearly 100 faculty members. These workshops offered a rare and valuable opportunity for trainee doctors from various specialties to engage directly with some of India’s foremost pulmonologists and gain practical experience under expert guidance.

Also Read:Pune: Army Institute of Cardio-Thoracic Sciences gets cardiopulmonary rehab centre

The conference was inaugurated by Lt Gen P. P. Rao, Director and Commandant of AFMC (Armed Forces Medical College). The keynote address was delivered by Padma Shri Dr Randeep Guleria, titled “Healthcare in 2030: Preparing for the Respiratory Revolution”, setting an insightful tone for the sessions to follow.

The conference included discussions on recent advancements in respiratory medicine, in-depth analyses of systemic diseases affecting the lungs, and thoughtful deliberations on the modern-day care of tuberculosis patients.

Organized by the Department of Respiratory Medicine, AICTS, Pune, the conference has drawn more than 150 faculty members and over 500 delegates from across the country. The event serves as a dynamic platform for the exchange of cutting-edge research, clinical insights, and innovative ideas.

Maj Gen P. K. Sharma, Commandant, AICTS and Organizing Chairperson, expressed great satisfaction at the successful inauguration of this landmark event. He highlighted that AICTS has been a pioneer in respiratory care since its inception in 1948, and emphasized the importance of such gatherings in fostering collaboration and innovation in the field.

Also Read:Army Hospital launches state-of-the-art Femto-LASIK Suite for spectacle removal

Powered by WPeMatico

Merck injectable version of blockbuster cancer therapy Keytruda gets USFDA approval

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph) injection for subcutaneous administration in adults across most solid tumor indications for KEYTRUDA (pembrolizumab).

Berahyaluronidase alfa is a variant of human hyaluronidase developed and manufactured by Alteogen Inc. KEYTRUDA QLEX must be administered by a health care provider (HCP). Merck expects to have KEYTRUDA QLEX (pronounced key-TRUE-duh Q-lex) available in the U.S. in late September.

“This approval is significant for patients and health care providers like me who have been using immunotherapies for years to treat certain cancers. We now have a new option with a broad set of indications that has demonstrated comparability with intravenous (IV) pembrolizumab but in a subcutaneous injection that can be administered in one minute every three weeks or two minutes every six weeks,” said Dr. J. Thaddeus Beck, oncologist and Medical Director of the Highlands’ Clinical Trials Office. “Subcutaneous pembrolizumab provides faster administration than IV pembrolizumab, offers two dosing options and gives patients more choices of health care settings in which they can receive their therapy.”

The pivotal trial comparing subcutaneous KEYTRUDA QLEX to IV KEYTRUDA administered every six weeks, each with chemotherapy, was conducted in patients with treatment-naïve metastatic non-small cell lung cancer (NSCLC) with no EGFR, ALK or ROS1 genomic tumor aberrations. This trial demonstrated comparable pharmacokinetic exposure levels to pembrolizumab [assessed as Cycle 1 AUC0-6 weeks (area under the curve from 0 to 6 weeks) and Cycle 3 (i.e. Steady State) Ctrough]. In descriptive efficacy analyses, overall response rates (ORR) were similar between KEYTRUDA QLEX and KEYTRUDA (45% [95% CI: 39, 52] vs 42% [95% CI: 33, 51]). Additionally, no notable differences were observed in progression-free survival (PFS) and overall survival (OS). Effectiveness of KEYTRUDA QLEX for its approved indications was established based on these data and pivotal trial data demonstrating comparable safety with KEYTRUDA, as well as evidence from adequate and well-controlled studies conducted with KEYTRUDA.

KEYTRUDA QLEX is contraindicated in patients with known hypersensitivity to berahyaluronidase alfa, hyaluronidase or to any of its excipients. 

As a subcutaneous injection, KEYTRUDA QLEX may provide added convenience compared to IV KEYTRUDA because it can be administered by HCPs in multiple settings from an infusion center to a doctor’s office or a local community-based clinic, providing more options where patients can receive their treatment. KEYTRUDA QLEX also provides flexibility in treatment administration. It can be given in one minute every three weeks or in two minutes every six weeks, requiring substantially less time to administer than a 30-minute IV infusion of KEYTRUDA, and also offers a choice of injection site in the thigh or abdomen avoiding the 5 cm area around the navel. For patients who do not require a port or whose veins are difficult to access, subcutaneous administration may simplify treatment administration.

“At Merck, we are committed to putting patients first, as we work relentlessly to discover new options that may help patients manage their treatment in a way that fits their needs,” said Dr. Marjorie Green, senior vice president and head of oncology, global clinical development, Merck Research Laboratories. “We are honored to build on the foundation of KEYTRUDA with KEYTRUDA QLEX, a new injectable immunotherapy option that has similar results to KEYTRUDA and can be administered in as little as one minute.”

“As part of supporting patients and families through their cancer journeys, we are excited to see patient-focused developments in subcutaneous cancer treatment that shorten administration time and may allow for more patients to receive treatment in multiple health care settings,” said Sally Werner, Chief Executive Officer, Cancer Support Community.

Powered by WPeMatico

KGMU doctors duped of Rs 23 lakh in investment scam, FIR against 3 colleagues

Lucknow: In a recent case of fraud, resident doctors from King George’s Medical University (KGMU), Lucknow, fell victim to an elaborate multi-level marketing (MLM) scheme, losing nearly Rs 23 lakh. They have registered an FIR against three of their colleagues, accusing them of cheating by promising high returns on investment. 

According to the complaint, the accused doctors posed as company representatives and convinced the junior and senior resident doctors to invest by promising high returns and a lavish lifestyle. 

They alleged that the accused lured them with fabricated documents and papers that showed large profits, luxury lifestyles, and photographs of supposed beneficiaries if they invested in the scheme.  

Also read- Unfortunate: 76-year-old doctor dies of heart attack after 3-day digital arrest

In the hope of huge returns, the residents transferred money both through credit cards and directly into the personal account of one of the doctors. They claimed that they were even pressured to sign papers at hotels under the guise of “general terms and conditions.” 

In some cases, they were asked to bring in their fellow colleagues, whose investments were also routed through them. Small payments, portrayed as “commission”, were given to make the scheme look real.

In this regard, the complainants also alleged that the accused doctors used their Aadhaar and PAN details in the scheme. They have accused the doctors of misusing their Aadhaar and PAN details to create fake email IDs, credit cards, and even fraudulent accounts on the company’s online portal, showing their relatives as new “investors” under them.

The suspicion that the scheme is fraudulent arose when some victims demanded their money back, but instead received threats with false cases, career sabotage, and even death from the accused doctors, as reported by TOI. 

The complainants further alleged that one of the accused doctors filed a false cyber complaint against one of them in Amethi, resulting in the freezing of his bank account.

The doctors said the fraud was a “well-planned racket” targeting medical professionals, designed to exploit trust among colleagues. Subsequently, they approached the police and registered an FIR against the three doctors of KGMU under relevant sections of the BNS.

Also read- Sangli doctor robbed of Rs 2 crore in Fake Income Tax Raid

Powered by WPeMatico